Charles W. Abbott

机构：Personalis (United States) · ORCID：0000-0002-3837-6471

发表论文 149 篇 · 总被引 1124 次 · h-index 17

代表论文

• Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk prediction (2025 · Cell · 被引 25)
• Ultrasensitive ctDNA monitoring reveals early predictors of immunotherapy response in advanced cancer (2026 · npj Precision Oncology · 被引 5)
• Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with Immunotherapy (2025 · Clinical Cancer Research · 被引 4)
• Ultrasensitive circulating tumor DNA (ctDNA) detection for prognostication in triple-negative breast cancer (TNBC) post-neoadjuvant chemotherapy (NAC). (2025 · Journal of Clinical Oncology · 被引 2)
• Abstract CT170: Neoadjuvant pembrolizumab stratified by tumor mutation burden in high-risk stage II-III dMMR/MSI colorectal cancer (NEOPRISM-CRC): Perioperative ultrasensitive ctDNA monitoring and tumor-infiltrating TCR repertoire for treatment response prediction (2026 · Cancer Research · 被引 1)
• Supplementary Figure 3 from Predictors of Immune Checkpoint Blockade Response in dMMR Colorectal Cancer Using an Integrated Immune-Enhanced Multiomics Platform (2026)